Philogen to attend the 13th World ADC conference in London on the 13th and 14th of March, 2023

On December 7, 2022 Philogen reported its attendance at World ADC2023 in London (Press release, Philogen, DEC 7, 2022, View Source [SID1234625357]). Dr. Samuele Cazzamalli (Head of Small Molecule Therapeutics at Philochem) is giving a lecture on the 14th of March 2023 entitled "Enhancing the Therapeutic Index of ADCs to Penetrate Solid Tumours: Pan-Tumoral Small Molecule-Drug Conjugates Targeting Fibroblast Activation Protein in Solid Lesions"

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Andrea Galbiati (Research Scientist at Philochem) is giving a lecture on the 13th of March 2023 entitled "Outlining FAP-Targeted Small Molecule Conjugates for the Delivery of Biocidal Radionuclides to the Tumour Microenvironment"